ASTCT and WBMT Webinar: Allogeneic Stem Cell Transplantation for Non-malignant Disorders: a Global Perspective

This webinar was organized by the Worldwide Network for Blood and Marrow Transplantation and the American Society for Transplantation and Cellular Therapy. The webinar provides an overview of the current knowledge and best practices for allogeneic stem cell transplantation (HCT) in patients with non-malignant disorders (NMD). 

Program and Speakers: 

- Welcome and Introduction: Yoshihisa Kodera and Domiano Rondelli

- The Global State of HCT for NMD: Results of the WBMT Survey

                Dietger Niederwieser - University of Leipzig, Germany

- What should we consider about the donor when performing HCT in NMD?

                Nina Worel - Medical University of Vienna, Austria

- HCT in Bone marrow failure syndromes: severe aplastic anemia-Fanconi anemia

                Nada Hamad - St Vincent´s Hospital, Sydney, Australia

- HCT in Thalassemia

                Vikram Mathews - Christian Medical College, Vellore, India

- HCT in sickle cell disease

                Selim Corbacioglu - University of Regensburg, Germany

- HCT for primary immunodeficiencies

                Carmem Bonfim - Hospital Pequeno Principe, Curitiba, Brazil

- Panel discussion: “Sharing experiences from different world regions”